-
Pfizer sees flat 2026 sales as it rebuilds drug pipeline
16 Dec 2025 18:31 GMT
… one of just two pharmaceutical companies that’s expected … Pfizer’s key drugs, like pneumonia vaccine Prevnar and heart treatment Vyndaqel, are … build its pipeline of medicines. The company recently won … begin 15 new obesity drug trials in 2026, Bourla said …
-
<![CDATA[A Pediatrician’s Perspective on the Latest ACIP Hepatitis B Vaccine Recommendations]]>
13 Dec 2025 01:52 GMT
… care providers should consider vaccine benefits, vaccine risks, and infection risks … in 1990, when we started vaccinating with Prevnar [pneumococcal immunization], we saw … maintain universal newborn hepatitis B vaccination. Press release. American Public …
-
FDA's Prasad tells staffers agency plans to get tougher on vaccine regulation, blames child deaths on COVID shots
02 Dec 2025 03:12 GMT
… FDA plans to "direct vaccine regulation towards evidence-based medicine … (randomized control trials).”
As anti-vaccine sentiment has grown … quarter earnings reports from drugmakers. Pfizer’s numbers … of its Prevnar franchise of pneumococcal vaccines were up …
-
FDA now has Merck, AZ and Sanofi RSV shots for infants in its crosshairs: Reuters
10 Dec 2025 00:17 GMT
… that have anchored the FDA’s globally respected scientific … of Medicine.
As for RSV shots, former Center for Drug Evaluation … showed it reduced hospital and doctor visits for RSV disease … sales of its Prevnar franchise of pneumococcal vaccines were up 18% …
-
Vaxcyte Doses First Participants in the OPUS Phase 3, Noninferiority Trial Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults
08 Dec 2025 12:00 GMT
… Capvaxive (PCV21) and Prevnar 20 (PCV20), … Drug Administration (FDA). Topline safety, tolerability and immunogenicity results from the OPUS trial … developed resistance to treatments. The morbidity … trials and regulatory plans; the demand for Vaxcyte’s vaccine …
-
<![CDATA[PCV13 Prevents Medically Attended Pneumococcal LRTI in Older Adults]]>
03 Dec 2025 18:12 GMT
… vaccine (PCV13, Prevnar 13; Pfizer) demonstrated real-world effectiveness in preventing medically … recommended when considering PCV13 vaccination.1,2
Pneumococcal disease … 13-valent pneumococcal conjugate vaccine against medically attended pneumococcal lower …
-
Conjugate Vaccine Market to Reach $33.99 Billion by 2029 with 12.4% CAGR
24 Nov 2025 10:00 GMT
… of Prevnar 20, a pneumococcal 20-valent conjugate vaccine by Pfizer Inc., an American pharmaceutical and biotech … firm, in Canada in June 2022. This vaccine …
-
In Q3, drugmakers saw a marked decline in US vaccine sales as Eli Lilly kicked into higher gear
24 Nov 2025 11:05 GMT
… sales of its Prevnar franchise of pneumococcal vaccines were up 18% year … ’s cancer treatment Keytruda as the current top-selling drug, a crown … Eylea knockoff, Pavblu. Its older medicines, like Prolia and Repatha—both …
-
What seniors need to know about this fall’s vaccines
07 Nov 2025 13:42 GMT
… are three different FDA approved flu vaccines (you only need … all covered under Medicare (Part D) prescription drug plans. But … doctor. Covid shots are covered by Medicare Part B.
Pneumonia Vaccines … never been vaccinated for pneumonia, the PCV20 (Prevnar 20) …
-
Pfizer's Prevnar, Abrysvo and Comirnaty suffer Q3 sales declines amid tough US market for vaccines
05 Nov 2025 03:58 GMT
… , Pfizer’s Prevnar family of pneumococcal vaccines, its respiratory … , Pfizer’s COVID treatment Paxlovid endured a precipitous … medicines grew sales 4% for the period.
In particular, the drugmaker … efforts to purchase obesity biotech Metsera. While Pfizer’ …